These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29437254)

  • 1. CRISPR/Cas9 knockout of USP18 enhances type I IFN responsiveness and restricts HIV-1 infection in macrophages.
    Taylor JP; Cash MN; Santostefano KE; Nakanishi M; Terada N; Wallet MA
    J Leukoc Biol; 2018 Feb; 103(6):1225-40. PubMed ID: 29437254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP18 (UBP43) Abrogates p21-Mediated Inhibition of HIV-1.
    Osei Kuffour E; Schott K; Jaguva Vasudevan AA; Holler J; Schulz WA; Lang PA; Lang KS; Kim B; Häussinger D; König R; Münk C
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISG15 Deficiency Enhances HIV-1 Infection by Accumulating Misfolded p53.
    Osei Kuffour E; König R; Häussinger D; Schulz WA; Münk C
    mBio; 2019 Aug; 10(4):. PubMed ID: 31455647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptor substrate-4 interacts with ubiquitin-specific protease 18 to activate the Jak/STAT signaling pathway.
    Jiao B; Shi X; Chen Y; Ye H; Yao M; Hong W; Li S; Duan X; Li Y; Wang Y; Chen L
    Oncotarget; 2017 Dec; 8(62):105923-105935. PubMed ID: 29285303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
    MacParland SA; Ma XZ; Chen L; Khattar R; Cherepanov V; Selzner M; Feld JJ; Selzner N; McGilvray ID
    J Virol; 2016 Jun; 90(12):5549-5560. PubMed ID: 27009955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction.
    Gargan S; Ahmed S; Mahony R; Bannan C; Napoletano S; O'Farrelly C; Borrow P; Bergin C; Stevenson NJ
    EBioMedicine; 2018 Apr; 30():203-216. PubMed ID: 29580840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells.
    Urin V; Shemesh M; Schreiber G
    J Mol Biol; 2019 Aug; 431(17):3324-3338. PubMed ID: 31207241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USP18 Mediates Interferon Resistance of Dengue Virus Infection.
    Ye H; Duan X; Yao M; Kang L; Li Y; Li S; Li B; Chen L
    Front Microbiol; 2021; 12():682380. PubMed ID: 34017322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. People with HIV-1 demonstrate type 1 interferon refractoriness associated with upregulated USP18.
    Sugawara S; El-Diwany R; Cohen LK; Rousseau KE; Williams CYK; Veenhuis RT; Mehta SH; Blankson JN; Thomas DL; Cox AL; Balagopal A
    J Virol; 2021 Apr; 95(10):. PubMed ID: 33658340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection.
    Randall G; Chen L; Panis M; Fischer AK; Lindenbach BD; Sun J; Heathcote J; Rice CM; Edwards AM; McGilvray ID
    Gastroenterology; 2006 Nov; 131(5):1584-91. PubMed ID: 17101330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of JAK-STAT Signaling by Epstein-Barr Virus Tegument Protein BGLF2 through Recruitment of SHP1 Phosphatase and Promotion of STAT2 Degradation.
    Jangra S; Bharti A; Lui WY; Chaudhary V; Botelho MG; Yuen KS; Jin DY
    J Virol; 2021 Sep; 95(20):e0102721. PubMed ID: 34319780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy.
    Gruber C; Martin-Fernandez M; Ailal F; Qiu X; Taft J; Altman J; Rosain J; Buta S; Bousfiha A; Casanova JL; Bustamante J; Bogunovic D
    J Exp Med; 2020 May; 217(5):. PubMed ID: 32092142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV blocks Type I IFN signaling through disruption of STAT1 phosphorylation.
    Nguyen NV; Tran JT; Sanchez DJ
    Innate Immun; 2018 Nov; 24(8):490-500. PubMed ID: 30282499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of elongation initiation factor 4E binding proteins by CRISPR/Cas9 enhances the antiviral response in porcine cells.
    Ramírez-Carvajal L; Singh N; de los Santos T; Rodríguez LL; Long CR
    Antiviral Res; 2016 Jan; 125():8-13. PubMed ID: 26592975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis.
    Santin I; Moore F; Grieco FA; Marchetti P; Brancolini C; Eizirik DL
    Cell Death Dis; 2012 Nov; 3(11):e419. PubMed ID: 23152055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP18 enhances dengue virus replication by regulating mitochondrial DNA release.
    Lai JH; Wu DW; Wu CH; Hung LF; Huang CY; Ka SM; Chen A; Ho LJ
    Sci Rep; 2023 Nov; 13(1):20126. PubMed ID: 37978268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of SOCS1 increases interferon-induced ISGylation during differentiation of induced-pluripotent stem cells to hepatocytes.
    Edwards JS; Delabat SA; Badilla AD; DiCaprio RC; Hyun J; Burgess RA; Silva T; Dykxhoorn DM; Chen SX; Wang L; Ishida Y; Saito T; Thomas E
    JHEP Rep; 2022 Dec; 4(12):100592. PubMed ID: 36439639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.